Nitric oxide modulation in protective role of antidepressants against chronic fatigue syndrome in mice

Indian Journal of Pharmacology

Volumn 43, Issue 3, 2011, Pages 324-329

  Kumar, Anil ^a   Garg, Ruchika ^a   Gaur, Vaibhav ^a   Kumar, Puneet ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Anxiety; chronic fatigue syndrome; citalopram; imipramine; nitric oxide; oxidative stress

Indexed keywords

ARGININE; CATALASE; CITALOPRAM; GLUTATHIONE; IMIPRAMINE; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN PROTECTION; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; FORCED SWIMMING TEST; LIPID PEROXIDATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS;

EID: 79958264498     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.81506     Document Type: Article

References (27)

1. Demitrck MA. Chronic fatigue syndrome: A disease of the hypothalamic-pituitary- adrenal axis. Ann Med 1994;26:1-5.
2. Komaroff AL, Fagioli LR, Geiger AM. An examination of the working case defi nition of chronic fatigue syndrome. Am J Med 1996;100:56-64. (Pubitemid 26049327)
3. Singh A, Naidu PS, Gupta S, Kulkarni SK. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food 2002;5:211-20. (Pubitemid 36331634)
4. Radi R, Rodriguez M, Castro L, Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994;308:89-95. (Pubitemid 24172608)
5. Nijs J, De Meirleir K. Oxidative stress might reduce essential fatty acids in erythrocyte membranes of chronic fatigue syndrome patients. Nutr Neurosci 2004;7:251-3. (Pubitemid 40123579)
6. Kumar A, Garg R. Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations. Fundam Clin Pharmacol 2009;23:89-95.
7. Harkin A, Connor TJ, Burns MP, Kelly JP. Nitric oxide inhibitors augment the effect of serotonin re-uptake inhibitors in the forced swimming test. Eur Neuropsychopharmacol 2004;14:274-81. (Pubitemid 38649083)
8. Kumar P, Kumar A. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:100-8.
9. Kulkarni SK. Handbook of Experimental Pharmacology. Delhi: Vallabh Prakashan; 1999. p. 123-5.
10. Wills ED. Mechanism of lipid peroxide formation in animal tissues. Biochem J 1966;99:667-76.
11. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
12. Green LC, Wagner DA, Glagowski J. Analysis of nitrate, nitrite and [15N] nitrate in biological fl uids. Anal Biochem 1982;126:131-8. (Pubitemid 13203451)
13. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949;177:751-66.
14. Luck H. Catalase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. New York: Academic Press; 1971. p. 885-93.
15. Dhir A, Kulkarni SK. Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice. Pharmacol Biochem Behav 2008;89:563-71.
16. Terman M, Levine SM, Terman JS, Doherty S. Chronic fatigue syndrome and seasonal affective disorder: Comorbidity, diagnostic overlap, and implications for treatment. Am J Med 1998;105:115-24.
17. Kumar A, Garg R, Gaur V, Kumar P. Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice. Brain Res 2010;1311:73-80.
18. Vercoulen JH, Swanink CM, Galama JM, Fennis JF, Jongen PJ, Hommes OR, et al.. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: Development of a model. J Psychosom Res 1998;45:507-17. (Pubitemid 29421873)
19. Thomas MA, Smith AP. An investigation of the long-term benefi ts of antidepressant medication in the recovery of patients with chronic fatigue syndrome. Hum Psychopharmacol 2006;21:503-9. (Pubitemid 46062138)
20. Marcoli M, Maura G, Toratarolo M, Raiteri M. Trazodone is a potent agonist at 5-HT2C receptors mediating inhibition of the N-methyl-D-aspartate/ nitric oxide/ cyclic GMP pathway in rat cerebellum. J Pharmacol Exp Ther 1998;285:983-6. (Pubitemid 28277894)
21. Gaur V, Kumar A. Behavioral, biochemical and cellular correlates in the protective effect of sertraline against transient global ischemia induced behavioral despair: Possible involvement of nitric oxide-cyclic guanosine monophosphate study pathway. Brain Res Bull 2010;82:57-64.
22. Torres RL, Torresi LS, Gamaro GD, Fontella FU, Silveira PP, Moreira JSR, et al.. Lipid peroxidation and total radical-trapping potential of the lungs of rats submitted to chronic and subchronic stress. Braz J Med Biol Res 2004;37:185-92. (Pubitemid 38268149)
23. Harvey BH, Oosthuizen F, Brand L, Wegener G, Stein DJ. Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology [Berl] 2004;175:494-502. (Pubitemid 39362049)
24. Sanders P, Korf J. Neuroaetiology of chronic fatigue syndrome: An overview. World J Biol Psychiatry 2008;9:165-71.
25. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments. J Affect Disord 2001;64:43-51. (Pubitemid 32268670)
26. Warner DS, Sheng H, Batinic-Haberele I. Oxidants, antioxidants and the ischemic brain. J Exp Biol 2004;207:3221-31. (Pubitemid 39275296)
27. Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S, et al.. CAMP response element-mediated gene transcription is up-regulated by chronic antidepressant treatment. J Neurosci 2000;20:4030-6. (Pubitemid 30365673)